We propose to employ a molecular approach to develop effective strategies for inducing specific immunologic unresponsiveness at the level of a transplanted organ allograft. This is based on recent evidence that aberrant signal transduction arising from inappropriate antigen presentation affects binding of nuclear regulatory factors to promoter regions of lymphokine genes and probably others to cause lymphocyte inactivation &/or reprogramming, and a growing body of evidence that limiting numbers T lymphocytes which have undergone such a functional switch serve to modulate alloimmune responses within the microenvironnent of a graft.
Specific Aim 1 defines heterogeneity of antigen receptors expressed by infiltrating T cells for defined epitopes borne by the graft.
Specific Aim 2 addresses the susceptibility of functional and phenotypically distinguishable T cell clones to inactivation/reprogramming.
Specific Aim 3 defines molecular correlates of lymphocytes activation in states of graft rejection and conditioned unresponsiveness.
Specific Aim 4 tests the thesis that of an oligoclonal population of T lymphocytes which have undergone a functional switch are driven by antigen to run an alternate program and serve to generate a state of conditioned unresponsiveness within the microenvironment of the graft which permits long term survival of the organ. An analysis of the determinants of conditioned unresponsiveness at the level of the organ allograft may permit new strategies for modulating the (allo)immune response in clinical transplantation and autoimmune disease to be developed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI030732-03
Application #
3145777
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1991-07-01
Project End
1996-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
3
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Goebel, J; Forrest, K J; Mikovits, J et al. (2001) STAT5 pathway: target of anti-CD4 antibody in attenuation of IL-2 receptor signaling. Transplantation 71:792-6
Goebel, J; Franks, A; Robey, F et al. (1999) Attenuation of IL-2 receptor signaling by CD4-ligation requires polymerized cytoskeletal actin but not P56LCK. Transplant Proc 31:822-4
Lowry, R P; Goebel, J (1999) Down-modulation of IL-2-triggered JAK3-STAT5 signaling following CD4-ligand binding. Transplant Proc 31:820-1
Lakkis, F G; Konieczny, B T; Saleem, S et al. (1997) Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol 158:2443-8
Saleem, S; Konieczny, B T; Lowry, R P et al. (1996) Acute rejection of vascularized heart allografts in the absence of IFNgamma. Transplantation 62:1908-11
Lowry, R P; Konieczny, B; Alexander, D et al. (1995) Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice. Transplant Proc 27:392-4
Pearson, T C; Alexander, D Z; Winn, K J et al. (1994) Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701-6
Lowry, R P; Takeuchi, T; Cremisi, H et al. (1993) Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously. Transplant Proc 25:2103-5
Lowry, R P; Takeuchi, T; Cremisi, H et al. (1993) Th2-like effectors may function as antigen-specific suppressor cells in states of transplantation tolerance. Transplant Proc 25:324-6
Larsen, C P; Ritchie, S C; Pearson, T C et al. (1992) Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations. J Exp Med 176:1215-20